Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SPAR Group, Inc.SGRP · Entity 7681 | Director | October 14, 2021 | November 05, 2021 |
| Zomedica Corp.ZOMDF · Entity 6884 | Director | March 17, 2025 | November 18, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SPAR Group, Inc.
Report date October 14, 2021 · Filed November 05, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option to buy Common Stock, $.01 par valueSEC Table II · derivative / convertible security · Conversion / exercise price $1.44 · Expires 2032-10-14 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2021-10-14 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: Vests as to 12,500 shares on each of October 14, 2022, 2023, 2024 and 2025, respectively. |
Filing footnotes · ownership attribution and instrument terms
F1: Vests as to 12,500 shares on each of October 14, 2022, 2023, 2024 and 2025, respectively.
Zomedica Corp.
Report date March 17, 2025 · Filed November 18, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $0.10 · Expires 2035-11-16 | Direct | 1,975,033 |
Reported balance
After 2025-11-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-11-17 · Grant · Acquired 1,975,033 · Balance 1,975,033 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 17, 2025 Filed Nov 18, 2025 21:45 UTC | Zomedica Corp. ZOMDF · Entity 6884 | GrantStock Appreciation Right · Derivative | 1,975,033 | $0.00 Strike: $0.10 | $0.00 |
DisclosureSEC source: 0001654954-25-013229 · section16.xml · derivative · entry 1 Whelan Sean · CIK 0001418307 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,975,033 Underlying: Common · 1,975,033 shares Expires 2035-11-16 Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 21:14 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantStoock Appreciation Rights · Derivative | 1,975,033 | $0.00 Strike: $0.13 | $0.00 |
DisclosureSEC source: 0001654954-24-014272 · section16.xml · derivative · entry 1 Whelan Sean · CIK 0001418307 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,975,033 Underlying: Common · 1,975,033 shares Expires 2034-11-10 Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 23:14 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantOptions to Buy Common Stock · Derivative | 1,157,153 | $0.00 Strike: $0.19 | $0.00 |
DisclosureSEC source: 0001654954-22-016443 · section16.xml · derivative · entry 1 Whelan Sean · CIK 0001418307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,157,153 Underlying: Common Stock · 1,157,153 shares Expires 2022-12-09 F1 · derivative.exercise_date: The stock options vest annually in four equal installments commencing on December 9, 2023. Read SEC document |
| September 13, 2021 Filed Sep 13, 2021 20:33 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantStock Option (right to buy) · Derivative | 800,000 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001171843-21-006452 · ownership.xml · derivative · entry 1 Whelan Sean · CIK 0001418307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800,000 Underlying: Common Shares, without par value · 800,000 shares Expires 2031-09-13 F1 · derivative.exercise_date: The option vests in 4 equal annual installments commencing September 13, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.